FINWIRES · TerminalLIVE
FINWIRES

CVS Caremark Reaches Settlement With FTC to Deliver Affordable Prescription Medicine

By

CVS Caremark (CVS) said Tuesday it has reached a global settlement with the Federal Trade Commission, which further advances the company's ability to deliver affordable prescription drugs.

The settlement resolves all outstanding FTC litigation and investigations related to CVS Health, involving rebate, pharmacy network contracting, and vertical integration issues, the company said.

Many of the measures in the agreement align with CVS Caremark's current affordability and transparency efforts, including point-of-sale rebate options, flat-dollar copays, copay caps, $0 preventive drug lists, and the TrueCost pricing model, each meant to reduce patient costs and offer greater clarity about drugs, the company added.

Price: $105.94, Change: $+0.04, Percent Change: +0.04%

Related Articles

Wire

Rithm Property Trust Launches Public Offering of Common Shares

Rithm Property Trust (RPT) said late Monday it launched a public offering of common shares.The company will grant underwriters a 30-day overallotment option to buy an additional 15% of the shares offered, according to a statement.An affiliate Rithm Capital has shown interest in buying common shares in a concurrent private placement, according to the company.Net proceeds will be used to acquire a portfolio of multifamily residential transition loans from affiliates of Rithm Capital, and for general corporate purposes, the company said.

$RPT
Wire

Penguin Solutions Plans $650 Million Convertible Notes Offering

Penguin Solutions (PENG) intends to offer $650 million in convertible senior notes due 2031 to institutional buyers, with initial purchasers expected to receive an option to buy up to an additional $100 million in notes, the company said Monday in a statement.Penguin expects to use the net proceeds to fund capped call transactions, pay the cash portion of exchanges for its existing 2029 and 2030 convertible notes, repay $100 million outstanding under its credit agreement, and for general corporate purposes.The company's shares fell 4.4% in after-hours trading.

$PENG
Wire

Erasca Plans $500 Million Underwritten Offering of Common Stock

Erasca (ERAS) plans to sell $500 million in common stock in an underwritten public offering.Underwriters are expected to receive a 30-day option to buy up to an additional $75 million in shares, the company said Monday in a statement.Erasca expects to use the net proceeds to finance research and development, and for working capital and general corporate purposes.The company's shares fell 2.2% in after-hours trading.

$ERAS